Guru Ownership Trend
Guru Analysis for Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.68 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $31.34 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Steven Cohen reduced exposure by 95.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Tyra Biosciences, Inc. (TYRA)
Major holders include Steven Cohen ($1.49 M), Cliff Asness ($1.13 M), Ken Fisher ($1.1 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 113,357 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $31.34 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TYRA. The total reported sell value was $31.99 M.
Yes, 1 managers opened new positions in TYRA, and 1 increased their existing holdings. The total reported buy value was $654,010.63.